Proprietary BD Vialon biomaterial softens up to 70% in the vein, enabling longer dwell times and reducing the chance of mechanical phlebitis by up to 50%.

Provides quick blood visualization that may help improve insertion success and therefore reduce insertion attempts.

Reduces dislodgement by 84% ^2§ and complies with the Infusion Therapy Standards of Practice and CDC guidelines for catheter stabilization. ^4,5

Shown to significantly reduce blood exposure during insertion compared to an open system ^2* and aligns with INS guidelines. ⁴